Efficacy and safety of nilotinib in steroid-refractory chronic graft-versus-host disease: A systematic review and meta-analysis

Eshak I. Bahbah, Mahmoud Ali, Osama Elshabasy, Mahmoud Attia

Open source

DOI
10.1016/j.trim.2026.102415
Published
2026-08
Container
Transplant Immunology
Publisher
Elsevier BV
Open access
unknown

Credibility signals

uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1016/j.trim.2026.102415,
  title = {Efficacy and safety of nilotinib in steroid-refractory chronic graft-versus-host disease: A systematic review and meta-analysis},
  author = {Eshak I. Bahbah and Mahmoud Ali and Osama Elshabasy and Mahmoud Attia},
  year = {2026},
  journal = {Transplant Immunology},
  doi = {10.1016/j.trim.2026.102415},
  url = {https://doi.org/10.1016/j.trim.2026.102415}
}

RIS

TY  - JOUR
TI  - Efficacy and safety of nilotinib in steroid-refractory chronic graft-versus-host disease: A systematic review and meta-analysis
AU  - Eshak I. Bahbah
AU  - Mahmoud Ali
AU  - Osama Elshabasy
AU  - Mahmoud Attia
PY  - 2026
JO  - Transplant Immunology
DO  - 10.1016/j.trim.2026.102415
UR  - https://doi.org/10.1016/j.trim.2026.102415
ER  - 

APA

Bahbah, E. I., Ali, M., Elshabasy, O., & Attia, M. (2026). Efficacy and safety of nilotinib in steroid-refractory chronic graft-versus-host disease: A systematic review and meta-analysis. Transplant Immunology. https://doi.org/10.1016/j.trim.2026.102415

Source records